Global Mangiferin Market Size is valued at USD 213.2 Million in 2024 and is predicted to reach USD 436.5 Million by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034.
Mangiferin is a polyphenolic substance that is present mainly in the fruits. Its potent antioxidant properties constitute a significant factor in the rising demand for beauty products. Environmental elements that cause accelerated aged skin, including contamination, sunlight, and harmful free radicals, may cause creases, tiny lines, and a lack of skin suppleness. Due to its antioxidant properties, it is commonly used as one of the ingredients in anti-ageing moisturizers, medications, and creams to maintain young, healthy skin. The demand for mangiferin has grown significantly due to increasing consumer knowledge of the biological compound's health advantages. As the pharma and chemical industries recognize mangiferin's medicinal potential, the market provides an opportunity to grow.
However, the high cost of its extraction and purification poses the main challenge. Furthermore, the products with mangiferin are usually cost premium, which may make them unaffordable to some individuals. Moreover, the availability of substitute natural substances with comparable health advantages may make it difficult for the demand for mangiferin to grow in popularity.
Some major key players in the mangiferin market:
- Chemcopia Ingredients Pvt Ltd (India)
- Biosynth (Switzerland)
- Merck KGaA (Germany)
- Cayman Chemical (U.S.)
- Santa Cruz Biotechnology Inc (U.S.)
- Extrasynthese (France)
- Selleck Chemicals (U.S.)
- Biorbyt Ltd. (U.K.)
- BOC Sciences (U.S)
- CliniSciences.
Market Segmentation:
The mangiferin market is segmented based on source, form, purity and application. Based on the source, the market is segmented into mango and other sources. The market is segmented by form into powder, liquid, and others. The market is segmented by purity into 98%, 95%, and 90%. The market is segmented by application into pharmaceuticals and nutraceuticals, food and beverages, cosmetics and personal care, and other applications.
Based on the Source, the Powder Segment is Accounted as a Major Contributor to the Mangiferin Market
The powder is expected to hold a significant global market share in 2025 in the mangiferin market because of its accuracy in dosage and ease of use. Customers who want the health advantages of mangiferin in a straightforward and convenient form select capsules. The increasing acceptance of personal care and the growing recognition of nutritional products are expected to increase the availability of mangiferin powder.
Cosmetics and Personal Care Segment to Witness Growth at a Rapid Rate
The cosmetics and personal care segment is growing in the mangiferin market because consumers are increasingly inclining toward renewable and natural components in personal care products. The popularity of natural substances like mangiferin is being fueled by consumers' growing awareness of the contents of cosmetics and skincare items. Its capacity to reduce free radicals and support skin health aligns with the growing movement toward clean beauty and happiness, which is driving this market's explosive expansion.
The Asia-Pacific Mangiferin market holds a significant revenue share in the region.
The Asia-Pacific mangiferin market is expected to register the highest market share in revenue in the near future. This can be attributed to the growing use of mangiferin in the pharmacological and dietary sectors. The need for safe and efficient health supplements is driven by the rising incidence of chronic illnesses and the expanding trend of preventative healthcare. The marketplace accessibility of skincare based on mangiferin can be further expanded through partnerships with skincare companies and focused advertising initiatives.
Mangiferin Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 213.2 Million |
|
Revenue Forecast In 2034 |
USD 436.5 Million |
|
Growth Rate CAGR |
CAGR of 7.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Source, Form, Purity, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South-East Asia; South Korea |
|
Competitive Landscape |
Chemcopia Ingredients Pvt Ltd (India), Biosynth (Switzerland), Merck KGaA (Germany), Cayman Chemical (U.S.), Santa Cruz Biotechnology, Inc (U.S.), Extrasynthese (France), Selleck Chemicals (U.S.), Biorbyt Ltd. (U.K.), BOC Sciences (U.S), CliniSciences (Spain) |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
